The Infectious Disease Society of America recommends that all patients with candidemia undergo a dilated retinal exam to exclude endogenous Candida endophthalmitis. The objective of this project was to determine if there are significant risk factors in candidemic patients for developing endogenous Candida endophthalmitis.
Dr. Rebekah Moehring and Dr. Thomas Holland talked with Clinical Infectious Diseases Journal about compiling observational research ruring a pandemic.
Led by DCASIP Clinical Ressearch Coordinator (CRC) Bobby Warren, along with CRC Alicia Nelson and Medical Director Dr. Dev Anderson, a team from multiple medical centers in the CDC Prevention Epicenters Program worked to find the impact of preoperative chlorhexidine gluconate (CHG) application methods on preoperative CHG skin concentration.
The primary objective of this study by the CDC Epicenters Program, led by DCASIP Clinical Research Coordinator Bobby Warren, was to determine the effectiveness of two enhanced disinfection strategies compared to standard disinfection: “near-UV” light (Arm 1) and a persistent organosilane quaternary ammonium disinfectant (Arm 2) using a triple-blind study design. The secondary objective was to characterize environmental contamination of outpatient clinics.
Antimicrobial resistance is a major challenge for modern healthcare. The Duke Center for Antimicrobial Stewardship and Infection Prevention includes a unique portfolio of programs to fight this growing problem. We at CDC look forward to continuing our collaborations with Duke to help protect patients.
Dr Anderson and colleagues in the Duke Center for Antimicrobial Stewardship and Infection Prevention are world leaders in the important and essential fight to prevent infections and antimicrobial resistance. They are truly providing the 'guiding lights' and leadership for all to follow in this mission.
The Duke Center for Antimicrobial Stewardship and Infection Prevention is an important source for education and programmatic support for hospitals in the Southeastern US. In addition, their research on the epidemiology of multidrug-resistant pathogens and enhancing antibiotic stewardship is of high quality and public health value. I look forward to collaborating with Dr. Anderson and his expert colleagues for years to come.